A new software algorithm decides which patients are most likely to become infected with the virus. But this is not like other risk calculators, some experts say. Source: NYT > Business – Gina Kolata
In preliminary tests, a matchstick-size rod containing a new drug offered promise as a shield against the virus. But a large clinical trial must still be done. Source: NYT > Business – Donald G. McNeil Jr.
Strategies abound to end the AIDS epidemic, but expense — mostly for drugs costing up to $50,000 a year — is the inevitable obstacle. Source: NYT > Business – DONALD G. McNEIL Jr.